LOW-DOSE ORAL PROPYLTHIOURACIL IN THE TREATMENT OF PLAQUE PSORIASIS

被引:14
作者
ELIAS, AR
BARR, RJ
机构
关键词
D O I
10.1111/j.1365-4362.1995.tb00635.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:519 / 520
页数:2
相关论文
共 7 条
[1]   MODULAR STRUCTURE OF A CHICKEN LYSOZYME SILENCER - INVOLVEMENT OF AN UNUSUAL THYROID-HORMONE RECEPTOR-BINDING SITE [J].
BANIAHMAD, A ;
STEINER, C ;
KOHNE, AC ;
RENKAWITZ, R .
CELL, 1990, 61 (03) :505-514
[2]   PROPYLTHIOURACIL IN PSORIASIS - RESULTS OF AN OPEN TRIAL [J].
ELIAS, AN ;
GOODMAN, MM ;
LIEM, WH ;
BARR, RJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 29 (01) :78-81
[3]   METHIMAZOLE (2-MERCAPTO 1-METHYL IMIDAZOLE) IN PSORIASIS - RESULTS OF AN OPEN TRIAL [J].
ELIAS, AN ;
GOODMAN, MM ;
ROHAN, MK ;
ALPERN, K ;
BARR, RJ .
DERMATOLOGY, 1993, 187 (01) :26-29
[4]   EFFECTS OF METHIMAZOLE ON HUMAN-LYMPHOCYTE PROLIFERATION AND NATURAL-KILLER CELL-ACTIVITY [J].
SHARMA, BS ;
ELIAS, AN .
GENERAL PHARMACOLOGY, 1987, 18 (04) :449-453
[5]   THIONAMIDES AND ARSENITE INHIBIT SPECIFIC T3 BINDING TO THE HEPATIC NUCLEAR RECEPTOR [J].
TAKAGI, S ;
HUMMEL, BCW ;
WALFISH, PG .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1990, 68 (03) :616-621
[6]   INHIBITION OF IMMUNOGLOBULIN-SECRETING CELLS BY ANTITHYROID DRUGS [J].
WEISS, I ;
DAVIES, TF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (06) :1223-1228
[7]   THE EFFECT OF ANTITHYROID DRUGS ON B-CELL AND T-CELL ACTIVITY INVITRO [J].
WILSON, R ;
MCKILLOP, JH ;
CHOPRA, M ;
THOMSON, JA .
CLINICAL ENDOCRINOLOGY, 1988, 28 (04) :389-397